Catch issues before they derail you product launch.

The Problem: When Insights Arrive Too Late

It’s week three after the new product launch. Early monitoring shows a growing spike of negative sentiment toward the product compared to competing products – though sentiment was well above parity on launch day. Pharmacies are reporting patient concerns. Medical information calls are higher than expected. You have thousands of pieces of feedback but no clear picture of what’s driving the problem.

Using ordinary tools, your team might take weeks to comb through the textual feedback to reveal those drivers of negative sentiment that weren’t flagged for monitoring in advance of the launch day. Three weeks from now, you’ll be at week six. Thousands of patients will have discontinued. Prescribers will have formed opinions. The launch trajectory will be set.

The speed of identifying and resolving key issues determines launch success – or failure. By the time your analysis delivers answers several weeks later, the critical early period has already passed: you’re just getting an explanation of what went wrong instead of arming yourself with the insights you need to fix the situation.

RxLaunch™ Provides Timely Insights

RxLaunch™ by Megaputer Intelligence is a pharmaceutical launch intelligence platform that uses AI agents to transform launch feedback into actionable insights in just a matter of hours, allowing your team to recognize and respond to key issues as they emerge in real-time.

You load in all your feedback: patient comments, prescriber notes, medical information calls, pharmacy reports, support tickets, and other data. RxLaunch’s AI agents perform semantic analysis of the texts and generate a hierarchy of informative tags that organize the feedback. Next, the system determines which issues are driving the key performance indicators (KPIs) such as stakeholder sentiment, adherence, or patient discontinuation. Notably, RxLaunch does not require you to specify the patterns that you are looking for in advance.

RxLaunch™ ingests launch feedback, discovers emerging issues, and ranks the issues by impact on selected KPIs

You receive a prioritized action list showing exactly which issues to address first. This list shows which issues are actually driving your KPIs, and which issues can be safely ignored. No need to train a neural network. No category definitions. No technical expertise required. The RxLaunch agents do all the work and deliver insights in an easy to comprehend form.

How One Pharma Company Saved Its Launch

Note: The following scenario is a hypothetical example designed to illustrate potential applications and outcomes. Specific metrics and results are for illustrative purposes only.

A pharmaceutical company launched a chronic disease medication. Launch day went smoothly. Week one looked promising. But by week three, early data showed a problem: sentiments were slipping compared to competing products. The launch was losing momentum at the worst possible time – during the critical early weeks when market position gets established.

The company had the feedback: pharmacist notes, medical information calls, patient comments, online discussions – tens of thousands of text records in all. What they didn’t have was clarity. But the use of RxLaunch enabled them to analyze the incoming data daily, automatically organizing and prioritizing issues as they emerged.

RxLaunch revealed that the drop in sentiment from patients and providers was being driven by a surprising issue – “refrigeration”. This was unexpected, since the product did not require refrigeration. Drilling down into the subtopics of the refrigeration category showed “can’t travel with medication,” “does not fit with lifestyle,” and surprisingly, mentions of a specific injection pen for an unrelated product in a different therapeutic area.

A closer inspection of the records showed that the product’s injection pen bore a superficial resemblance to another widely-used injection pen for a medication that required refrigeration. Even though the injection pen was for a different therapeutic category, and made by a different manufacturer, the superficial similarities in mechanism, appearance, and size caused some patients to draw a parallel. Those patients who’d used the other injector pen were instinctively storing the new medication the same way – and convincing others to do the same.

The refrigeration myth was spreading virally. During week one, just 2-3% of patients were refrigerating due to individual confusion. But by week three, that number had risen to 14%. Projections showed that the myth would have spread to a majority of patients by week eight if the trend had continued.

Refrigeration didn’t harm the drug, but it destroyed adherence. Patients could forget doses when traveling, skip injections when away from home overnight, or just find the cold-storage routine burdensome. Many who believed the myth said that the product was “too inconvenient,” and often stopped refilling.

Rapid Response and Recovery

Acting on this insight, the company moved immediately. Within a day, the patient support and communications teams began posting clarifications in online communities where misinformation was spreading. In parallel, pharmacy hotlines and patient support staff were briefed to proactively correct the misconception during inbound calls and chat interactions. Within a week, pharmacists received an updated counseling cue card: “Storage: room temperature; do not refrigerate.” Automated text messages on day two and day seven reminded patients to store the product at room temperature.

Within eight weeks, belief in the refrigeration myth had dropped to almost zero. Patient and provider sentiment recovered, regaining full parity with competing products. Six-month refill rates came in at 72%, two points above projection.

Traditional analysis might have taken weeks to find the issue. In those extra weeks, the product’s image would have been irreparably tarnished. While the myth would have eventually been discovered and put down, first impressions among patients and healthcare providers cannot easily be corrected. The product would have been permanently positioned as “the inconvenient one,” with low adherence and high discontinuation.

RxLaunch found what no one thought to look for, quantified what might have been dismissed, and delivered it before viral spread made the problem unfixable. In this case, the speed of discovery and response to new insights drew the line between success and failure.

What make RxLaunch Different

The refrigeration myth was just one of many insights brought to light by RxLaunch. While competing product launch monitoring solutions rely on crude algorithms that struggle to find patterns beyond what they are told to look for, RxLaunch takes a fundamentally different approach. Our AI agents work like expert human analysts – discovering and organizing issues in real-time, making intelligent decisions at every step.

These agents don’t just search for predefined problems – they autonomously identify what’s actually driving your KPIs, even unexpected issues you never thought to monitor. As new patterns emerge in your feedback, the agents adapt and refine their analysis automatically.

The result: comprehensive, intelligent, actionable insights from day one. No blind spots from forgotten categories. No critical patterns buried in the noise of massive unstructured datasets. Just intelligent agents working around the clock to surface the issues that matter most for launch success.

Who This Is For

RxLaunch is designed for pharmaceutical teams responsible for product launch success:

• Launch Directors who need real-time visibility into emerging issues that could derail commercial performance during the critical early weeks
• Brand Teams who must protect market positioning and respond quickly to unexpected competitive dynamics or patient perception shifts
• Medical Affairs who handle complex medical information inquiries and need to identify systemic clinical or product questions emerging across touchpoints
• Patient Support Teams who manage frontline feedback but lack tools to quickly identify patterns that signal broader adherence or satisfaction issues
• Commercial Operations Leaders who must make fast, data-driven decisions to protect launch investments and adjust tactics in real-time
• Market Access Teams who need to understand and address payer, pharmacy, and access barriers before they become widespread adoption blockers
• Field Teams who need actionable intelligence about prescriber concerns and patient feedback to guide their conversations and remove obstacles to uptake

If your team is responsible for a product launch and you’re swimming in feedback data but struggling to identify which issues actually matter, consider RxLaunch. It transforms unstructured data into clear, prioritized action items – before problems become unfixable.

Your next launch is coming. The feedback will accumulate. The critical issues will emerge in early data. The only question: will you have insights when the launch opportunity window is still open, or will you only receive a report explaining what went wrong when it’s too late?

See how RxLaunch works

Read more about the AI agents powering RxLaunch